Search for Clinical Trial Results
Hemolytic-Uremic Syndrome - 25 Studies Found
Status | Study |
Terminated |
Study Name: aHUS Observational Long Term Follow-Up Condition: Atypical Hemolytic Uremic Syndrome Date: 2012-01-18 |
Recruiting |
Study Name: Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults Condition: Hemolytic Uremic Syndrome Date: 2016-09-08 Interventions: Biological: Extra blood draw samples |
Terminated |
Study Name: Complement Inhibition in aHUS Dialysis Patients Condition: Atypical Hemolytic Uremic Syndrome Date: 2015-05-26 Interventions: Drug: CCX168 |
Completed |
Study Name: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS Condition: Atypical Hemolytic Uremic Syndrome Date: 2009-02-13 Interventions: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Study Name: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS Condition: Atypical Hemolytic Uremic Syndrome Date: 2009-02-13 Interventions: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Study Name: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS Condition: Atypical Hemolytic Uremic Syndrome Date: 2009-02-12 Interventions: Drug: eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Study Name: The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome (aHUS) Date: 2012-12-04 Interventions: Drug: Eculizumab |
Recruiting |
Study Name: Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome (aHUS) Date: 2016-10-25 Interventions: Biological: ALXN1210 Single loading dose on Day 1, followe |
Completed |
Study Name: To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients Condition: ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) Date: 2012-12-04 |
Enrolling by invitation |
Study Name: Eval. of Potential Predictors of Disease Progression in Patients With aHUS Including Genetics, Biomarkers and Treatment Condition: Atypical Hemolytic Uremic Syndrome Date: 2015-11-24 Interventions: Other: Clinical assessments and laboratory tests. Clinical assessments and laboratory tests required at |